Parameters Delta, n=490 Omicron, n=272 P
Time between onset of symptoms and start of the antiviral treatment, mean ± SD (min–max)
5.1 ± 3.0 (0-21) n=479 3.5 ± 2.2 (0-14) n=266
<0.001
Patient treated within 5 days of symptoms, % (n) 57.2 (274 /479) 86.8 (231/266) <0.001
Patient treated within 3 days of symptoms, % (n) 27.8 (133/479) 53.4 (142/266) <0.001
Immunomodulators, % (n) 56.3 (276) 55.9 (152) >0.05
Tocilizumab 14.9 (73) 9.6 (26) 0.04
Dexamethason 49.6 (243) 54.4 (148) >0.05
Baricitinib 1.2 (6) 3.3 (9) 0.04
Antibiotics, % (n) 34.1 (167) 41.2 (112) 0.05
Low molecular weight heparin in prophylactic dose, % (n) 73.1 (358) 73.5 (200) >0.05
Low molecular weight heparin in a therapeutic dose, % (n) 16.9 (83) 23.5 (64) 0.03